Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026)

Johnson & Johnson's (JNJ) quarterly Restructuring Costs came in at $34.0 million in Q2 2026, down 46.88% year-over-year from $64.0 million in Q2 2025, and up 6.25% quarter-over-quarter from $32.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Restructuring Costs (2010 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Restructuring Costs across 13 years of filings, most recently posting $34.0 million for Q2 2026.

  • In Q2 2026, Restructuring Costs fell 46.88% year-over-year to $34.0 million; the TTM figure through Jun 2026 stood at $213.0 million (up 29.88% YoY), while the FY2025 annual figure was $228.0 million, down 2.56% from the prior year.
  • Restructuring Costs came in at $34.0 million for Q2 2026 at Johnson & Johnson, up from $32.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $164.0 million in Q1 2024 to a low of -$13.0 million in Q2 2024.
  • Average Restructuring Costs over 5 years is $74.6 million, with a median of $64.5 million recorded in 2022.
  • Year-over-year, Restructuring Costs slumped 108.97% in 2024 and surged 592.31% in 2025.
  • Over 5 years, Restructuring Costs stood at $65.0 million in 2022, then retreated by 13.85% to $56.0 million in 2023, then declined by 25.0% to $42.0 million in 2024, then soared by 100.0% to $84.0 million in 2025, then sank by 59.52% to $34.0 million in 2026.
  • Per Business Quant data, the three most recent Restructuring Costs figures were $34.0 million in Q2 2026, $32.0 million in Q1 2026, and $84.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 34.00 Mn
Mar 29, 2026 32.00 Mn
Dec 28, 2025 84.00 Mn
Sep 28, 2025 63.00 Mn
Jun 29, 2025 64.00 Mn
Mar 30, 2025 17.00 Mn
Dec 29, 2024 42.00 Mn
Sep 29, 2024 41.00 Mn
Jun 30, 2024 -13.00 Mn
Mar 31, 2024 164.00 Mn
Dec 31, 2023 56.00 Mn
Oct 1, 2023 158.00 Mn
Jul 2, 2023 145.00 Mn
Apr 2, 2023 130.00 Mn
Jan 1, 2023 106.00 Mn
Oct 2, 2022 65.00 Mn
Jul 3, 2022 85.00 Mn
Apr 3, 2022 70.00 Mn
Oct 3, 2021 60.00 Mn
Jul 4, 2021 56.00 Mn